Clin2
NCT06959368Likely a fitRecruiting

New H. pylori treatment vs standard triple therapy

Helicobacter Pylori Infection

Treatments studied

Part of Infections clinical trials.

This trial compares a newer drug (vonoprazan) plus antibiotics to the standard triple therapy for eradicating H. pylori infection in the stomach. It may be a good option if you have stomach symptoms like indigestion, acid reflux, or a non-bleeding ulcer and have not been treated for H. pylori before.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 4
Enrollment
484 people
Ages
18 years to 80 years
Study type
Interventional

Who can take part

  • You are between 18 and 80 years old
  • You have indigestion, acid reflux, or a non-bleeding stomach ulcer
  • You tested positive for H. pylori infection
  • You have not taken acid-reducing medications (PPIs) for the last 2 weeks
  • You have not taken any antibiotics in the last month
  • You have never been treated for H. pylori before

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07537634Recruiting· Phase 4
New stomach acid medicine versus standard treatment for H. pylori infection

This trial compares two different antibiotic combinations to treat H. pylori, a common stomach bacteria that causes indigestion and ulcers. One uses a newer acid-blocking medicine (vonoprazan) and the other uses a standard one (esomeprazole), both paired with antibiotics.

Dhaka
NCT07624422Not yet recruiting· Phase 4
Two antibiotic combinations for H. pylori stomach infection

This study compares two different antibiotic treatment plans for H. pylori, a common stomach bacteria that causes ulcers and digestive problems. The trial tests whether a higher dose of one medication (vonoprazan) works better than a different antibiotic combination.

Damascus
NCT06929962Recruiting· Phase 4
VA dual sequential therapy for H. pylori gastritis

This trial tests a new two-step antibiotic treatment for adults with chronic gastritis caused by H. pylori bacteria. If you have not been treated for H. pylori before and are between 18 and 70, you may be able to join.

Nanjing, Jiangsu
NCT07439445Recruiting
Simplified treatment for H. pylori guided by a stool test

This trial tests a simpler two-drug treatment for H. pylori infection, chosen based on a stool test that checks if the bacteria are resistant to clarithromycin. It may help people who have not been treated before avoid unnecessary antibiotics.

Beijing, Beijing Municipality
NCT07242456Recruiting· Phase 2/Phase 3
Comparing two treatments for H. pylori infection

This study tests two different combinations of medications to treat H. pylori, a stomach bacteria that can cause ulcers. You would take one of the two combinations for a short time to see which works better at getting rid of the infection.

Hangzhou, Zhejiang
NCT07358130Recruiting
Comparing two treatments for H. pylori infection

This trial tests two different ways to treat Helicobacter pylori (H. pylori), a bacteria that can cause stomach ulcers. One treatment combines three medicines (bismuth, amoxicillin, and vonoprazan), and the other uses four medicines (bismuth quadruple therapy). The goal is to see which works better.

Kaohsiung City

Hear when a new Helicobacter Pylori Infection trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.